Item 4.01 of this Current Report on Form 8-K
to Grant Thornton. Grant Thornton has
furnished the Company with a letter dated February 11, 2008 addressed to
the Securities and Exchange Commission stating that it agrees with such
statements. A copy of such letter is filed as Exhibit 16.1 to this Current
Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibit is filed with this Current Report on Form 8-K:
|
Exhibit No. |
|
Description |
|
|
16.1 |
|
Letter from Grant Thornton LLP dated February 11, 2008. |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 11, 2008
|
|
TAPESTRY PHARMACEUTICALS, INC. |
|
|
|
|
|
|
|
By: |
/s/ Gordon H. Link, Jr. |
|
|
|
Gordon H. Link, Jr. |
|
|
|
Senior Vice President and Chief Financial Officer |
INDEX TO EXHIBITS
|
Exhibit No. |
|
Description |
|
|
16.1 |
|
Letter from Grant Thornton LLP dated February 11, 2008. |
|